...
首页> 外文期刊>Journal of Medicinal Chemistry >Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
【24h】

Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.

机译:TSAO-T的无碱基类似物,是第一种特异性抑制HIV-1逆转录酶的糖衍生物。

获取原文
获取原文并翻译 | 示例

摘要

With the aim of assessing the role that the thymine base of TSAO-T may play in the interaction of TSAO compounds with HIV-1 reverse transcriptase (RT), we have designed, synthesized, and evaluated for their anti-HIV-1 activity a series of 3-spiro sugar derivatives substituted at the anomeric position with nonaromatic rings or with amine, amide, urea, or thiourea moieties that mimic parts or the whole thymine base of TSAO-T. Also, a dihydrouracil TSAO analogue and O-glycosyl 3-spiro sugar derivatives substituted at the anomeric position with methyloxy or benzyloxy groups have been prepared. Compounds substituted at the anomeric position with an azido, amino, or methoxy group, respectively, were devoid of marked antiviral activity (EC50: 10-200 microM). However, the substituted urea sugar derivatives led to an increase in antiviral potency (EC50: 0.35-4 microM), among them those urea derivatives that mimic most closely the intact TSAO-T molecule retained the highest antiviral activity. Also, the dihydrouracil TSAO derivative retained pronounced anti-HIV-1 activity. None of the compounds showed any anti-HIV-2 activity. The results described herein represent the first examples of sugar derivatives that interact in a specific manner with HIV-1 RT. Molecular modeling studies carried out with a prototype urea derivative indicate that a heteroaromatic ring is not an absolute requirement for a favorable interaction between TSAO-T and HIV-1 RT. Urea derivatives, which can mimic to a large extent both the shape and the electrostatic potential of a thymine ring, can effectively replace this nucleic acid base when incorporated into a TSAO molecular framework with only moderate loss of activity.
机译:为了评估TSAO-T的胸腺嘧啶碱基在TSAO化合物与HIV-1逆转录酶(RT)相互作用中可能发挥的作用,我们设计,合成并评估了它们的抗HIV-1活性。系列的3-螺糖衍生物,在异头位置被非芳族环或被胺,酰胺,脲或硫脲部分取代,它们模拟TSAO-T的部分或整个胸腺嘧啶碱基。同样,已经制备了二氢尿嘧啶TSAO类似物和在异头位置被甲氧基或苄氧基取代的O-糖基3-螺糖衍生物。在异头位置分别被叠氮基,氨基或甲氧基取代的化合物没有明显的抗病毒活性(EC50:10-200 microM)。然而,取代的脲糖衍生物导致抗病毒效力增加(EC50:0.35-4 microM),其中最紧密地模仿完整TSAO-T分子的那些脲衍生物保留了最高的抗病毒活性。同样,二氢尿嘧啶TSAO衍生物保留了明显的抗HIV-1活性。这些化合物均未显示出任何抗HIV-2活性。本文所述的结果代表了以特定方式与HIV-1 RT相互作用的糖衍生物的第一个实例。用原型尿素衍生物进行的分子模型研究表明,杂芳环并不是TSAO-T与HIV-1 RT之间良好相互作用的绝对要求。可在很大程度上模拟胸腺嘧啶环的形状和静电势的尿素衍生物,当掺入到TSAO分子框架中时,仅具有中等程度的活性损失,就可以有效地取代该核酸碱基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号